Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018213 · ClinicalTrials.gov registry record · NA
Naltrexone and Patch for Smokers
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
NCT00018213 is a NA study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00018213, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The aim of this study is to investigate the effects of naltrexone, alone and combined with nicotine patch, on responses of smokers to smoking cues after 10 hours of tobacco deprivation. Smokers who are not seeking treatment will be assigned to one of six conditions: They will receive either 50 mg of naltrexone or a placebo pill, and also will wear a nicotine patch that has 0, 21, or 42 mg of nicotine during the tobacco deprivation period. Both the day before the medication and deprivation and at the end of 10 hours of deprivation all will be exposed to lit cigarette cues in the laboratory. Effects of the medications will be assessed on withdrawal measures, urge to smoke, psychophysiological measures, and the topography of smoking three test cigarettes. Studies such as these can help to identify potential interventions for tobacco cessation or withdrawal, and thereby could result in less suffering and mortality.
Interventions
- DRUG Naltrexone Hydrochloride
- DRUG Transdermal Nicotine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-04 |
| Est. Completion | 2001-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018213
The ClinicalTrials.gov registry entry for NCT00018213 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Naltrexone Hydrochloride is the first listed.
NCT00018213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018213 about?
NCT00018213 is a clinical study titled "Naltrexone and Patch for Smokers". The aim of this study is to investigate the effects of naltrexone, alone and combined with nicotine patch, on responses of smokers to smoking cues after 10 hours of tobacco deprivation. Smokers who are not seeking treatment will be assigned to one of six conditions: They will receive either 50 mg of...
What is the current status of trial NCT00018213?
This trial is currently completed. It is a NA study. The study started on 1998-04. Estimated completion is 2001-03.
What interventions are being tested in trial NCT00018213?
The interventions under investigation include: Naltrexone Hydrochloride (DRUG), Transdermal Nicotine (DRUG).
Who is sponsoring clinical trial NCT00018213?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.